| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
159,210,000 |
| Market
Cap: |
1.10(B) |
| Last
Volume: |
2,204,422 |
Avg
Vol: |
2,198,459 |
| 52
Week Range: |
$2.7 - $7.11 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Amneal Pharmaceuticals is a holding company. Through its subsidiaries, Co. is a pharmaceutical company engaging in developing, manufacturing, marketing and distributing generic and branded pharmaceutical products across an array of dosage forms and therapeutic areas. Co. has three reportable segments: Generics, which includes various product families covering a range of dosage forms and delivery systems; Specialty, which is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products, with a focus on products addressing central nervous system disorders; and AvKARE, which provides pharmaceuticals, medical and surgical products, and services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nestor Michael |
President, Impax Pharm. Div. |
• – – |
2009-03-13 |
4 |
B |
$5.59 |
$11,180 |
I/I |
2,000 |
2,000 |
1.99 |
- |
|
| Hildenbrand Charles V |
SVP, Operations |
• – – |
2009-03-13 |
4 |
B |
$5.75 |
$28,750 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
| Mengler Christopher |
President, Global Pharm. Div. |
• – – |
2009-03-12 |
4 |
B |
$5.50 |
$27,500 |
D/D |
5,000 |
45,000 |
2.74 |
- |
|
| Mengler Christopher |
President, Global Pharm. Div. |
• – – |
2009-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
40,000 |
|
- |
|
| Mengler Christopher |
President, Global Pharm. Div. |
• – – |
2009-03-03 |
4 |
B |
$6.00 |
$60,000 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| Hsu Larry |
President and CEO |
• • – |
2009-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
9,200 |
21,949 |
|
- |
|
| Koch Arthur A Jr |
SVP, Finance, and CFO |
• – – |
2009-01-27 |
4 |
B |
$5.00 |
$25,000 |
D/D |
5,000 |
10,000 |
2.74 |
- |
|
| Hsu Larry |
President and CEO |
• • – |
2009-01-27 |
4 |
B |
$5.00 |
$250,000 |
D/D |
50,000 |
2,533,771 |
2.81 |
- |
|
| Hsu Larry |
President and CEO |
• • – |
2009-01-23 |
4 |
B |
$3.80 |
$49,020 |
D/D |
12,900 |
2,483,771 |
2.81 |
- |
|
| Koch Arthur A Jr |
SVP, Finance, and CFO |
• – – |
2009-01-22 |
4 |
B |
$3.99 |
$19,938 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
| Hsu Larry |
President and CEO |
• • – |
2009-01-22 |
4 |
B |
$3.98 |
$346,353 |
D/D |
87,100 |
2,470,871 |
2.81 |
- |
|
| Hsu Larry |
President and CEOOfficer |
• • – |
2008-12-09 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
2,383,317 |
|
- |
|
| Hsu Larry |
President and CEOOfficer |
• • – |
2008-12-09 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
16,543 |
|
- |
|
| Nestor Michael |
President, Impax Pharm. Div.Of |
• – – |
2008-12-09 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
32,575 |
|
- |
|
| Sun Oh Kim |
Director |
– • – |
2008-12-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
16,679 |
|
- |
|
| Hsu Larry |
President and CEOOfficer |
• • – |
2008-12-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,383,771 |
|
- |
|
| Nestor Michael |
President, Impax Pharm. Div.Of |
• – – |
2008-12-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,575 |
|
- |
|
| Fleming Nigel |
Director |
– • – |
2008-12-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,000 |
|
- |
|
| Burr Robert L |
Director |
– • – |
2008-12-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
29,150 |
|
- |
|
| Burr Robert L |
Director |
– • – |
2008-12-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,057 |
|
- |
|
| Benet Leslie Z |
Director |
– • – |
2008-12-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,000 |
|
- |
|
| Benet Leslie Z |
Director |
– • – |
2008-12-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
600 |
|
- |
|
| Chu May |
Sr. VP Quality Affairs |
• – – |
2005-03-02 |
4 |
B |
$14.36 |
$1,996 |
D/D |
139 |
55,427 |
2.66 |
- |
|
| Hsu Larry |
President |
• • – |
2005-03-02 |
4 |
B |
$14.36 |
$1,996 |
D/D |
139 |
2,383,910 |
2.73 |
- |
|
| Hsiao Charles |
Director |
– • – |
2005-03-02 |
4 |
B |
$14.36 |
$1,996 |
D/D |
139 |
3,610 |
2.31 |
- |
|
531 Records found
|
|
Page 19 of 22 |
|
|
0.11 (1.57%) 
